NCT06520384View on ClinicalTrials.gov

Radiofrequency Applications and Alcoholic Neurolysis of Genicular Nerve for the Treatment of Knee Osteoarthritic Pain

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 25, 2024

Primary Completion Date

January 5, 2025

Study Completion Date

January 5, 2025

Conditions
RadiofrequencyAlcoholGenicular NerveKnee OsteoarthritisPain
Interventions
DEVICE

Radiofrequency

Patients will receive radiofrequency.

DRUG

Alcohol 30%

Patients will receive ultrasound-guided injection of each of the three genicular nerves with 0.5-0.75 ml of a solution containing 30% alcohol in 0.25% bupivacaine.

DRUG

Alcohol 50%

Patients will receive ultrasound-guided injection of each of the three genicular nerves with 0.5-0.75 ml of a solution containing 50% alcohol in 0.25% bupivacaine.

DRUG

Alcohol 70%

Patients will receive ultrasound-guided injection of each of the three genicular nerves with 0.5-0.75 ml of a solution containing 70% alcohol in 0.25% bupivacaine.

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06520384 - Radiofrequency Applications and Alcoholic Neurolysis of Genicular Nerve for the Treatment of Knee Osteoarthritic Pain | Biotech Hunter | Biotech Hunter